APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nonsteroidal MRAs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nonsteroidal MRAs Market Outlook and Growth Opportunities 2026

29 December 2025193 pages

Choose your research edition.

Industry ResearchNonsteroidal MRAs Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonsteroidal MRAs Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Nonsteroidal MRAs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonsteroidal MRAs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nonsteroidal MRAs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nonsteroidal MRAs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nonsteroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nonsteroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nonsteroidal MRAs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nonsteroidal MRAs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nonsteroidal MRAs market include Daiichi Sankyo, Bayer and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nonsteroidal MRAs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nonsteroidal MRAs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nonsteroidal MRAs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nonsteroidal MRAs market size, projected growth trends, production technologies, key applications, and end-use industries.

Nonsteroidal MRAs Segment by Company

Daiichi Sankyo

Bayer

Sun Pharma

Nonsteroidal MRAs Segment by Type

Finerenone

Esaxerenone

Others

Nonsteroidal MRAs Segment by Application

Heart Failure

Diabetic Nephropathy

Hypertension

Others

Nonsteroidal MRAs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nonsteroidal MRAs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nonsteroidal MRAs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nonsteroidal MRAs significant trends, drivers, influence factors in global and regions.

6. To analyze Nonsteroidal MRAs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonsteroidal MRAs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonsteroidal MRAs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonsteroidal MRAs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nonsteroidal MRAs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nonsteroidal MRAs industry.

Chapter 3: Detailed analysis of Nonsteroidal MRAs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nonsteroidal MRAs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nonsteroidal MRAs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nonsteroidal MRAs Industry Trends Table 2. Nonsteroidal MRAs Industry Drivers Table 3. Nonsteroidal MRAs Industry Opportunities and Challenges Table 4. Nonsteroidal MRAs Industry Restraints Table 5. Global Nonsteroidal MRAs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nonsteroidal MRAs Revenue Share by Company (2021-2026) Table 7. Global Nonsteroidal MRAs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nonsteroidal MRAs Sales Volume Share by Company (2021-2026) Table 9. Global Nonsteroidal MRAs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nonsteroidal MRAs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nonsteroidal MRAs Key Company Manufacturing Base & Headquarters Table 12. Global Nonsteroidal MRAs Company, Product Type & Application Table 13. Global Nonsteroidal MRAs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nonsteroidal MRAs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Finerenone Table 18. Significant Companies of Esaxerenone Table 19. Significant Companies of Others Table 20. Global Nonsteroidal MRAs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Nonsteroidal MRAs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Nonsteroidal MRAs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Nonsteroidal MRAs Sales Volume Share by Type (2021-2026) Table 24. Global Nonsteroidal MRAs Sales Volume Share by Type (2027-2032) Table 25. Global Nonsteroidal MRAs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nonsteroidal MRAs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Nonsteroidal MRAs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Nonsteroidal MRAs Sales Value Share by Type (2021-2026) Table 29. Global Nonsteroidal MRAs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Heart Failure Table 31. Significant Companies of Diabetic Nephropathy Table 32. Significant Companies of Hypertension Table 33. Significant Companies of Others Table 34. Global Nonsteroidal MRAs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Nonsteroidal MRAs Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Nonsteroidal MRAs Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Nonsteroidal MRAs Sales Volume Share by Application (2021-2026) Table 38. Global Nonsteroidal MRAs Sales Volume Share by Application (2027-2032) Table 39. Global Nonsteroidal MRAs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Nonsteroidal MRAs Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Nonsteroidal MRAs Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Nonsteroidal MRAs Sales Value Share by Application (2021-2026) Table 43. Global Nonsteroidal MRAs Sales Value Share by Application (2027-2032) Table 44. Global Nonsteroidal MRAs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Nonsteroidal MRAs Sales by Region (2021-2026) & (K Units) Table 46. Global Nonsteroidal MRAs Sales Market Share by Region (2021-2026) Table 47. Global Nonsteroidal MRAs Sales by Region (2027-2032) & (K Units) Table 48. Global Nonsteroidal MRAs Sales Market Share by Region (2027-2032) Table 49. Global Nonsteroidal MRAs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nonsteroidal MRAs Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Nonsteroidal MRAs Sales Value Share by Region (2021-2026) Table 52. Global Nonsteroidal MRAs Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Nonsteroidal MRAs Sales Value Share by Region (2027-2032) Table 54. Global Nonsteroidal MRAs Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Nonsteroidal MRAs Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Nonsteroidal MRAs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Nonsteroidal MRAs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Nonsteroidal MRAs Sales by Country (2021-2026) & (K Units) Table 59. Global Nonsteroidal MRAs Sales Market Share by Country (2021-2026) Table 60. Global Nonsteroidal MRAs Sales by Country (2027-2032) & (K Units) Table 61. Global Nonsteroidal MRAs Sales Market Share by Country (2027-2032) Table 62. Global Nonsteroidal MRAs Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Nonsteroidal MRAs Sales Value Market Share by Country (2021-2026) Table 64. Global Nonsteroidal MRAs Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Nonsteroidal MRAs Sales Value Market Share by Country (2027-2032) Table 66. Daiichi Sankyo Company Information Table 67. Daiichi Sankyo Business Overview Table 68. Daiichi Sankyo Nonsteroidal MRAs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Daiichi Sankyo Nonsteroidal MRAs Product Portfolio Table 70. Daiichi Sankyo Recent Development Table 71. Bayer Company Information Table 72. Bayer Business Overview Table 73. Bayer Nonsteroidal MRAs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bayer Nonsteroidal MRAs Product Portfolio Table 75. Bayer Recent Development Table 76. Sun Pharma Company Information Table 77. Sun Pharma Business Overview Table 78. Sun Pharma Nonsteroidal MRAs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sun Pharma Nonsteroidal MRAs Product Portfolio Table 80. Sun Pharma Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. Nonsteroidal MRAs Distributors List Table 84. Nonsteroidal MRAs Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Nonsteroidal MRAs Product Image Figure 2. Global Nonsteroidal MRAs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nonsteroidal MRAs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nonsteroidal MRAs Sales (2021-2032) & (K Units) Figure 5. Global Nonsteroidal MRAs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nonsteroidal MRAs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Finerenone Image Figure 10. Esaxerenone Image Figure 11. Others Image Figure 12. Global Nonsteroidal MRAs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Nonsteroidal MRAs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Nonsteroidal MRAs Sales Volume Share by Type (2021-2032) Figure 15. Global Nonsteroidal MRAs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nonsteroidal MRAs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nonsteroidal MRAs Sales Value Share by Type (2021-2032) Figure 18. Heart Failure Image Figure 19. Diabetic Nephropathy Image Figure 20. Hypertension Image Figure 21. Others Image Figure 22. Global Nonsteroidal MRAs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Nonsteroidal MRAs Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Nonsteroidal MRAs Sales Volume Share by Application (2021-2032) Figure 25. Global Nonsteroidal MRAs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Nonsteroidal MRAs Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Nonsteroidal MRAs Sales Value Share by Application (2021-2032) Figure 28. Global Nonsteroidal MRAs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Nonsteroidal MRAs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Nonsteroidal MRAs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Nonsteroidal MRAs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Nonsteroidal MRAs Sales Value (2021-2032) & (US$ Million) Figure 33. North America Nonsteroidal MRAs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Nonsteroidal MRAs Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Nonsteroidal MRAs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Nonsteroidal MRAs Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Nonsteroidal MRAs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Nonsteroidal MRAs Sales Value (2021-2032) & (US$ Million) Figure 39. South America Nonsteroidal MRAs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Nonsteroidal MRAs Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Nonsteroidal MRAs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Nonsteroidal MRAs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Nonsteroidal MRAs Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Nonsteroidal MRAs Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Finerenone
  • Esaxerenone
  • Others
Applications
  • Heart Failure
  • Diabetic Nephropathy
  • Hypertension
  • Others
Companies covered
  • Daiichi Sankyo
  • Bayer
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nonsteroidal MRAs Sales Value (2021-2032)
  4. 1.2.2 Global Nonsteroidal MRAs Sales Volume (2021-2032)
  5. 1.2.3 Global Nonsteroidal MRAs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nonsteroidal MRAs Market Dynamics
  1. 2.1 Nonsteroidal MRAs Industry Trends
  2. 2.2 Nonsteroidal MRAs Industry Drivers
  3. 2.3 Nonsteroidal MRAs Industry Opportunities and Challenges
  4. 2.4 Nonsteroidal MRAs Industry Restraints
3 Nonsteroidal MRAs Market by Company
  1. 3.1 Global Nonsteroidal MRAs Company Revenue Ranking in 2025
  2. 3.2 Global Nonsteroidal MRAs Revenue by Company (2021-2026)
  3. 3.3 Global Nonsteroidal MRAs Sales Volume by Company (2021-2026)
  4. 3.4 Global Nonsteroidal MRAs Average Price by Company (2021-2026)
  5. 3.5 Global Nonsteroidal MRAs Company Ranking (2024-2026)
  6. 3.6 Global Nonsteroidal MRAs Company Manufacturing Base and Headquarters
  7. 3.7 Global Nonsteroidal MRAs Company Product Type and Application
  8. 3.8 Global Nonsteroidal MRAs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nonsteroidal MRAs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nonsteroidal MRAs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nonsteroidal MRAs Market by Type
  1. 4.1 Nonsteroidal MRAs Type Introduction
  2. 4.1.1 Finerenone
  3. 4.1.2 Esaxerenone
  4. 4.1.3 Others
  5. 4.2 Global Nonsteroidal MRAs Sales Volume by Type
  6. 4.2.1 Global Nonsteroidal MRAs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nonsteroidal MRAs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Nonsteroidal MRAs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Nonsteroidal MRAs Sales Value by Type
  10. 4.3.1 Global Nonsteroidal MRAs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nonsteroidal MRAs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Nonsteroidal MRAs Sales Value Share by Type (2021-2032)
5 Nonsteroidal MRAs Market by Application
  1. 5.1 Nonsteroidal MRAs Application Introduction
  2. 5.1.1 Heart Failure
  3. 5.1.2 Diabetic Nephropathy
  4. 5.1.3 Hypertension
  5. 5.1.4 Others
  6. 5.2 Global Nonsteroidal MRAs Sales Volume by Application
  7. 5.2.1 Global Nonsteroidal MRAs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nonsteroidal MRAs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Nonsteroidal MRAs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Nonsteroidal MRAs Sales Value by Application
  11. 5.3.1 Global Nonsteroidal MRAs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Nonsteroidal MRAs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Nonsteroidal MRAs Sales Value Share by Application (2021-2032)
6 Nonsteroidal MRAs Regional Sales and Value Analysis
  1. 6.1 Global Nonsteroidal MRAs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nonsteroidal MRAs Sales by Region (2021-2032)
  3. 6.2.1 Global Nonsteroidal MRAs Sales by Region: 2021-2026
  4. 6.2.2 Global Nonsteroidal MRAs Sales by Region (2027-2032)
  5. 6.3 Global Nonsteroidal MRAs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nonsteroidal MRAs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nonsteroidal MRAs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nonsteroidal MRAs Sales Value by Region (2027-2032)
  9. 6.5 Global Nonsteroidal MRAs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nonsteroidal MRAs Sales Value (2021-2032)
  12. 6.6.2 North America Nonsteroidal MRAs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nonsteroidal MRAs Sales Value (2021-2032)
  15. 6.7.2 Europe Nonsteroidal MRAs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nonsteroidal MRAs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nonsteroidal MRAs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nonsteroidal MRAs Sales Value (2021-2032)
  21. 6.9.2 South America Nonsteroidal MRAs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nonsteroidal MRAs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nonsteroidal MRAs Sales Value Share by Country, 2025 VS 2032
7 Nonsteroidal MRAs Country-level Sales and Value Analysis
  1. 7.1 Global Nonsteroidal MRAs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nonsteroidal MRAs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nonsteroidal MRAs Sales by Country (2021-2032)
  4. 7.3.1 Global Nonsteroidal MRAs Sales by Country (2021-2026)
  5. 7.3.2 Global Nonsteroidal MRAs Sales by Country (2027-2032)
  6. 7.4 Global Nonsteroidal MRAs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nonsteroidal MRAs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nonsteroidal MRAs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nonsteroidal MRAs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nonsteroidal MRAs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nonsteroidal MRAs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Daiichi Sankyo
  2. 8.1.1 Daiichi Sankyo Company Information
  3. 8.1.2 Daiichi Sankyo Business Overview
  4. 8.1.3 Daiichi Sankyo Nonsteroidal MRAs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Daiichi Sankyo Nonsteroidal MRAs Product Portfolio
  6. 8.1.5 Daiichi Sankyo Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Nonsteroidal MRAs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Nonsteroidal MRAs Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Sun Pharma
  14. 8.3.1 Sun Pharma Company Information
  15. 8.3.2 Sun Pharma Business Overview
  16. 8.3.3 Sun Pharma Nonsteroidal MRAs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharma Nonsteroidal MRAs Product Portfolio
  18. 8.3.5 Sun Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nonsteroidal MRAs Value Chain Analysis
  2. 9.1.1 Nonsteroidal MRAs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nonsteroidal MRAs Sales Mode & Process
  6. 9.2 Nonsteroidal MRAs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nonsteroidal MRAs Distributors
  9. 9.2.3 Nonsteroidal MRAs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst